Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

Active Filters

    Status Trial Number Title Activated Closed Sort ascending Accrual Phase Published
    Closed S0806 Phase I/II DLBCL Vorinostat with R-CHOP 11/15/2010 10/1/2013 100% Published
    Closed S1105 Text Messaging Study 3/27/2012 9/15/2013 100%
    Closed S1119 Water Contamination Study 12/2/2011 8/5/2013 100% Published
    Closed S1014 Metastatic PCa Suboptimal Response ADT, Abiraterone Acetate, Ph II 8/9/2011 8/1/2013 98% Published
    Closed S1106 Randomized Phase II Younger Patients Mantle Cell Lymphoma 10/1/2011 6/26/2013 29% Published
    Closed S1108 Phase II MLN8237 in Peripheral T-Cell NHL 10/28/2011 6/6/2013 100% Published
    Closed S0000D Adenomatous Colorectal Polyps (ACP) 6/3/2008 5/28/2013 100% Published
    Closed S1005 Ph II MK-2206 gastric and GEJ 1/1/2011 5/1/2013 100% Published
    Closed S0713 Ph II Rectal Pre-Operative ChemoRT 2/1/2009 4/15/2013 94% Published
    Closed S0927 Ph III Omega-3 fatty acid/placebo Breast Cancer 2/1/2012 2/1/2013 100% Published
    Closed S0816 Phase II Stage III-IV Hodgkin's: FDG-PET Imaging Study 7/1/2009 12/1/2012 100% Published
    Closed S0925 New Hormone-Sensitive Metastatic PCa, Androgen Deprivation +/- IMC-A12, Ph II 12/15/2010 12/1/2012 100% Published
    Closed S0809 Cholangiocarcinoma Ph II capecitabine, gemcitabine, RT 12/1/2008 10/1/2012 100% Published
    Closed S0800 ADVANCED: Phase II weekly Nab-Paclitaxel +/- Bevacizumab, Preceded or Followed by AC+PEG-G for Locally Advanced Her-2/Neu Neg Breast Cancer 4/1/2010 10/1/2012 100% Published
    Closed S0518 CARCINOID Ph III depot octreotide + either interferon alpha or bevacizumab 12/1/2007 9/1/2012 100% Published
    Closed S0337 Superficial Bladder, Post-TURBT Gemcitabine vs Saline, Ph III 7/15/2007 8/15/2012 100%
    Closed S0910 Cytarabine/Clofarabine +/- Epratuzumab for Relapsed/Refractory B-cell ALL 8/15/2010 7/1/2012 100% Published
    Closed S0720 Phase II Adjuvant NSCLC 11/15/2008 5/15/2012 100% Published
    Closed S0833 TT3: Ph II New MM for Pts </= 65 3/15/2011 5/1/2012 0%
    Closed S0500 ADVANCED: Therapeutic Strategy Using the CellSearch Assay for Metastatic Breast Cancer 10/1/2006 3/15/2012 100% Published
    Scroll Table